A phase I, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study evlauating the pharmacokinetics, pharmacodynamics, and tolerability of verinurad in healthy adult males
Latest Information Update: 05 Jul 2017
Price :
$35 *
At a glance
- Drugs Verinurad (Primary)
- Indications Gout; Hyperuricaemia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism
- 25 Jan 2017 New trial record